|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Car- bopol 934: An improved suspending agent for in- soluble test compounds 显示文摘 | Dolan M M Steelman R L Tumilowicz R R | 1960 | Toxicology and Ap- plied Pharmacology1960，2，3： | 1 |
| 2 | The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor responsive tumors显示文摘 | Weinstein Oppenheimer C R Blalock W L Steelman L S | 2000 | Pharmacol Ther2000，88，： | 1 |
| 3 | Raf-induced cell cy-cle progression in human tf-1 hematopoietic cells显示文摘 | Chang F Steelman L S McCubrey J A | 2002 | Cell Cy-cle2002，1，： | 1 |
| 4 | Ras/Raf/ MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to over- come resistance显示文摘 | McCubrey J A Steelman L S Chappell W H | 2012 | Oncotarget2012，3，10： | 1 |
| 5 | Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors显示文摘 | STEELMAN L S NAVOLANIC P M SOKOLOSKY M L | 2008 | Oncogene2008，27，29： | 1 |
| 6 | Roles, of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance 显示文摘 | McCubrey J A Steelman L S Chappell W H | 2007 | Biochim Biophys Acta2007，1773，8： | 1 |
| 7 | Synergy between an IGF-IR antibody and Raf/MEK! ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic ceils 显示文摘 | Bertrand F E Steelman L S Chappell W H | 2006 | Leukemia2006，20，7： | 1 |
| 8 | Roles of the Raf/MEK /ERK pathway in cell growth, malig-nant, transformation and drug resistance 显示文摘 | MC CUBREY J A STEELMAN L S CHAPPELL W H | 2007 | Biochim Biophys Acta2007，1773，8： | 1 |
| 9 | JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR -ABL in cell cycle progression and leukemogenesis 显示文摘 | STEELMAN L S POHNERT S C SHELTON J G | 2004 | Leukemia2004，18，2： | 1 |
| 10 | Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway显示文摘 | Steelman L S Shelton J G | 2003 | Int J Oncol2003，22，3： | 1 |
| 11 | Roles of the Raf/MEK/ERK pathway in cell growth, malign ant, transforma- tion and drug resistance 显示文摘 | McCubrey J A Steelman L S Chappell W H | 2007 | Biochim Biophys Acta2007，1773，8： | 1 |
| 12 | Targeting the leukemic stem cell:the holy grail of leukemia therapy显示文摘 | Misaghian N Ligresti G Steelman L S | 2009 | Leukemia2009，23，1： | 1 |
| 13 | Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance显示文摘 | McCubrey J A Steelman L s Abrams S L | | 0，，： | 1 |
| 14 | Roles of the Raf/MEK/ERK pathway in cell growth,malignant transformation and drug resistance显示文摘 | Mccubrey J A Steelman L S Chappell W H | 2007 | Biochim Biophys Acta2007，1773，8： | 1 |
| 15 | GSK-3 as potential target for therapeutic intervention in cancer显示文摘 | McCubrey J A Steelman L S Bertrand F E | 2014 | Oncotarget2014，5，10： | 1 |
| 16 | Roles of the Raf/MEK/ERK pathway in cell growth,malignant transformation and drug resistance显示文摘 | McCubrey J A Steelman L S Chappell W H | 2007 | BBA-Mol Cancer Res2007，1773，8： | 1 |
| 17 | Mitochondrial and ribosomal internal transcribed spacer Ⅰ diversity of Cimex lectularius (Hemiptera:Cimicidae)显示文摘 | Szalanski A L Austin J W MeKern J A Steelman C D and Gold R E | | 0，，： | 1 |
| 18 | Signal transduction mediated by the Ras/Raf /MEK/ERK pathway from cytokine receptors to transcription factors : potential targeting for therapeutic intervention 显示文摘 | Chang F Steelman L S Lee J T | 2003 | Leukemia2003，17，7： | 1 |
| 19 | The effect of doula support during labor on mother-infant interaction at 2 months显示文摘 | Martin S Landry S Steelman L te al | 1998 | Infant Behav Derel1998，21，： | 1 |
| 20 | Therapeutic resistance resulting from mutations in Raf/ MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways显示文摘 | MCCUBREY J A STEELMAN L S KEMPF C R | 2011 | J Cell Physiol2011，226，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员